Cellebrite Total Current Liabilities from 2010 to 2024
| CLBT Stock | USD 20.39 0.50 2.51% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 253.8 M | Current Value 199.5 M | Quarterly Volatility 53.2 M |
Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 4 M, Interest Income of 8.4 M or Depreciation And Amortization of 8 M, as well as many indicators such as Price To Sales Ratio of 6.58, Dividend Yield of 0.0818 or PTB Ratio of 50.54. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
Cellebrite | Total Current Liabilities |
Latest Cellebrite's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Cellebrite DI over the last few years. Total Current Liabilities is an item on Cellebrite balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cellebrite DI are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Cellebrite's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Cellebrite Total Current Liabilities Regression Statistics
| Arithmetic Mean | 133,242,235 | |
| Geometric Mean | 125,096,500 | |
| Coefficient Of Variation | 39.93 | |
| Mean Deviation | 45,442,980 | |
| Median | 99,160,000 | |
| Standard Deviation | 53,201,740 | |
| Sample Variance | 2830.4T | |
| Range | 154.7M | |
| R-Value | 0.81 | |
| Mean Square Error | 1040T | |
| R-Squared | 0.66 | |
| Significance | 0.0002 | |
| Slope | 9,655,749 | |
| Total Sum of Squares | 39626T |
Cellebrite Total Current Liabilities History
About Cellebrite Financial Statements
Cellebrite shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 253.8 M | 199.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.